Martin Pelchat

1.7k total citations
50 papers, 1.1k citations indexed

About

Martin Pelchat is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Martin Pelchat has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 19 papers in Molecular Biology and 15 papers in Infectious Diseases. Recurrent topics in Martin Pelchat's work include Hepatitis B Virus Studies (15 papers), RNA and protein synthesis mechanisms (15 papers) and Hepatitis C virus research (14 papers). Martin Pelchat is often cited by papers focused on Hepatitis B Virus Studies (15 papers), RNA and protein synthesis mechanisms (15 papers) and Hepatitis C virus research (14 papers). Martin Pelchat collaborates with scholars based in Canada, United States and Tunisia. Martin Pelchat's co-authors include Valerie S. Greco-Stewart, Lynda Rocheleau, Jacques Lapointe, Jean‐Pierre Perreault, Earl G. Brown, John M. Taylor, Yves Gagnon, R. Breton, M. Grunberg‐Manago and Harald Putzer and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Martin Pelchat

48 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Pelchat Canada 23 465 390 253 237 192 50 1.1k
Takuji Daito Japan 15 443 1.0× 615 1.6× 177 0.7× 263 1.1× 283 1.5× 19 1.2k
Siddharth R. Krishnamurthy United States 11 414 0.9× 173 0.4× 219 0.9× 100 0.4× 232 1.2× 12 970
Simone Hoppe Germany 8 249 0.5× 393 1.0× 97 0.4× 443 1.9× 230 1.2× 11 944
Natalya L. Teterina United States 18 515 1.1× 152 0.4× 261 1.0× 89 0.4× 443 2.3× 24 1.2k
Marianita Santiana United States 7 414 0.9× 198 0.5× 150 0.6× 88 0.4× 385 2.0× 9 1.0k
P. C. Joost Haasnoot Netherlands 11 486 1.0× 78 0.2× 129 0.5× 76 0.3× 108 0.6× 12 733
Marcelo López‐Lastra Chile 27 1.1k 2.4× 206 0.5× 130 0.5× 209 0.9× 416 2.2× 69 1.8k
Ann Kaminski United Kingdom 17 1.6k 3.5× 178 0.5× 243 1.0× 342 1.4× 417 2.2× 21 2.3k
Ronnie Hanecak United States 17 1.1k 2.4× 264 0.7× 323 1.3× 154 0.6× 621 3.2× 20 2.0k
Rui Pedro Galão United Kingdom 17 383 0.8× 249 0.6× 93 0.4× 64 0.3× 362 1.9× 22 1.1k

Countries citing papers authored by Martin Pelchat

Since Specialization
Citations

This map shows the geographic impact of Martin Pelchat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Pelchat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Pelchat more than expected).

Fields of papers citing papers by Martin Pelchat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Pelchat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Pelchat. The network helps show where Martin Pelchat may publish in the future.

Co-authorship network of co-authors of Martin Pelchat

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Pelchat. A scholar is included among the top collaborators of Martin Pelchat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Pelchat. Martin Pelchat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Galipeau, Yannick, Corey Arnold, Martin Pelchat, et al.. (2025). Autoantibodies targeting angiotensin‐converting enzyme 2 are prevalent and not induced by SARS ‐ CoV ‐2 infection. The FASEB Journal. 39(4). e70390–e70390.
2.
Almeida, N., Ian Schiller, Danbing Ke, et al.. (2024). The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study. Frontiers in Immunology. 15. 1330549–1330549. 3 indexed citations
3.
4.
Galipeau, Yannick, Danijela Konforte, Mohamed Abou El Hassan, et al.. (2023). Cross-sectional Characterization of SARS-CoV-2 Antibody Levels and Decay Rates Following Infection of Unvaccinated Elderly Individuals. Open Forum Infectious Diseases. 10(8). ofad384–ofad384. 2 indexed citations
5.
Bo, Yuxia, Nicholas D. LeBlond, Geneviève Laroche, et al.. (2021). Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments. PLoS Pathogens. 17(1). e1009275–e1009275. 15 indexed citations
6.
7.
Pelchat, Martin, et al.. (2018). The Hepatitis Delta Virus accumulation requires paraspeckle components and affects NEAT1 level and PSP1 localization. Scientific Reports. 8(1). 6031–6031. 26 indexed citations
8.
Rocheleau, Lynda, et al.. (2017). Influenza A virus cap-snatches host RNAs based on their abundance early after infection. Virology. 509. 167–177. 25 indexed citations
9.
Bondy‐Chorney, Emma, Aymeric Ravel‐Chapuis, Roscoe Klinck, et al.. (2016). Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier. PLoS Genetics. 12(1). e1005827–e1005827. 35 indexed citations
10.
11.
Rocheleau, Lynda, et al.. (2014). Deep sequencing reveals the eight facets of the influenza A/HongKong/1/1968 (H3N2) virus cap-snatching process. Scientific Reports. 4(1). 6181–6181. 33 indexed citations
12.
13.
Hu, Yu‐Wen, et al.. (2012). Hepatitis C virus: The role of molecular mimicry in response to interferon treatment. Journal of Medical Virology. 84(10). 1571–1585. 2 indexed citations
14.
Greco-Stewart, Valerie S., et al.. (2009). The hepatitis delta virus RNA genome interacts with the human RNA polymerases I and III. Virology. 386(1). 12–15. 40 indexed citations
15.
Greco-Stewart, Valerie S., et al.. (2006). The human RNA polymerase II interacts with the terminal stem–loop regions of the hepatitis delta virus RNA genome. Virology. 357(1). 68–78. 54 indexed citations
16.
Greco-Stewart, Valerie S., et al.. (2006). Binding of the polypyrimidine tract-binding protein-associated splicing factor (PSF) to the hepatitis delta virus RNA. Virology. 356(1-2). 35–44. 39 indexed citations
17.
Hu, Yu‐Wen, Lynda Rocheleau, Bryce Larke, et al.. (2005). Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2. Virology. 332(2). 538–549. 28 indexed citations
18.
Pelchat, Martin, Dominique Lévesque, Jonathan Ouellet, et al.. (2000). Sequencing of Peach Latent Mosaic Viroid Variants from Nine North American Peach Cultivars Shows that This RNA Folds into a Complex Secondary Structure. Virology. 271(1). 37–45. 37 indexed citations
19.
Pelchat, Martin. (2000). The database of the smallest known auto-replicable RNA species: viroids and viroid-like RNAs. Nucleic Acids Research. 28(1). 179–180. 10 indexed citations
20.
Pelchat, Martin, Yves Gagnon, Serge Laberge, & Jacques Lapointe. (1999). Co‐transcription of Rhizobium meliloti lysyl‐tRNA synthetase and glutamyl‐tRNA synthetase genes. FEBS Letters. 449(1). 23–27. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takuji Daito Breakdown of academic impact, for papers by Siddharth R. Krishnamurthy Breakdown of academic impact, for papers by Simone Hoppe Breakdown of academic impact, for papers by Natalya L. Teterina Breakdown of academic impact, for papers by Marianita Santiana Breakdown of academic impact, for papers by P. C. Joost Haasnoot Breakdown of academic impact, for papers by Marcelo López‐Lastra Breakdown of academic impact, for papers by Ann Kaminski Breakdown of academic impact, for papers by Ronnie Hanecak Breakdown of academic impact, for papers by Rui Pedro Galão
Rankless by CCL
2026